We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Radcal

Radcal is a premier provider of diagnostic X-ray measurements systems for quality assurance, manufacturing, service, ... read more Featured Products: More products

Download Mobile App




IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

By MedImaging International staff writers
Posted on 14 Feb 2024
Print article
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered into an agreement to acquire all the assets of Radcal Corporation (Monrovia, CA, USA), a leader in diagnostic X-ray measurement. With the acquisition of Radcal, IBA will further strengthen its Medical Imaging Quality Assurance offering as well as its presence in the US market.

Radcal, a pioneer in the X-ray imaging market, introduced the first instrument to provide comprehensive measures of X-ray dose with the capability to interchange sensors without any loss in accuracy, almost 50 years ago. The integration of Radcal into IBA’s business will aid its continued growth in the dosimetry and quality assurance field, further strengthening its foothold in the key US market and expanding its product offering beyond OEM and into the clinical setting.

“This acquisition strengthens our position as a global leader in Medical Imaging Dosimetry and Quality Assurance, complementing our leading position in the radiotherapy market and diversifying our revenue sources,” said Olivier Legrain, Chief Executive Officer at IBA. “We see tremendous potential for the combined business both in the US and the international market and look forward to working closely with the Radcal team to continue the strong growth of its leading offering.”

“We are delighted to welcome the talented and dedicated Radcal team to IBA group,” added Jean-Marc Bothy, President of IBA Dosimetry. “We are committed to providing the very best in medical imaging and radiotherapy quality assurance to our customers globally, contributing to our ultimate goal to treat more patients safely. Radcal’s growing product offering will enable us to reach new customers in the US and expand our presence in the Medical Imaging Quality Assurance market internationally.”

Related Links:
IBA
Radcal Corporation 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Portable X-Ray Unit
AJEX240H

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.